...
首页> 外文期刊>The Journal of biological chemistry >HDAC3-dependent Reversible Lysine Acetylation of Cardiac Myosin Heavy Chain Isoforms Modulates Their Enzymatic and Motor Activity
【24h】

HDAC3-dependent Reversible Lysine Acetylation of Cardiac Myosin Heavy Chain Isoforms Modulates Their Enzymatic and Motor Activity

机译:HDAC3依赖性可逆赖氨酸乙酰化心肌肌苷重链同种型的乙酰化调节其酶促和运动活性

获取原文
           

摘要

Reversible lysine acetylation is a widespread post-translational modification controlling the activity of proteins in different subcellular compartments. We previously demonstrated that a class II histone deacetylase (HDAC), HDAC4, and a histone acetyltransferase, PCAF, associate with cardiac sarcomeres, and a class I and II HDAC inhibitor, trichostatin A, enhances contractile activity of myofilaments. In this study, we show that a class I HDAC, HDAC3, is also present at cardiac sarcomeres. By immunohistochemical and electron microscopic analyses, we found that HDAC3 was localized to the A band of sarcomeres and was capable of deacetylating myosin heavy chain (MHC) isoforms. The motor domains of both cardiac α- and β-MHC isoforms were found to be reversibly acetylated. Biomechanical studies revealed that lysine acetylation significantly decreased the Km for the actin-activated ATPase activity of both α- and β-MHC isoforms. By an in vitro motility assay, we found that lysine acetylation increased the actin sliding velocity of α-myosin by 20% and β-myosin by 36%, compared to their respective non-acetylated isoforms. Moreover, myosin acetylation was found to be sensitive to cardiac stress. During induction of hypertrophy, myosin isoform acetylation increased progressively with duration of stress stimuli, independent of isoform shift, suggesting that lysine acetylation of myosin could be an early response of myofilaments to increase contractile performance of the heart. These studies provide the first evidence for localization of HDAC3 at myofilaments and uncover a novel mechanism modulating the motor activity of cardiac MHC isoforms.
机译:可逆赖氨酸乙酰化是一种广泛的翻译后修饰,控制不同亚细胞室中蛋白质的活性。我们以前证明,II类组蛋白脱乙酰化酶(HDAC),HDAC4和组蛋白乙酰转移酶,PCAF,与心脏肉体组织缔合品,以及I类和II HDAC抑制剂,Troichostatin A,增强了肌细胞的收缩活性。在这项研究中,我们表明,I类HDAC HDAC3也存在于心脏的SARCOMERES。通过免疫组织化学和电子显微镜分析,我们发现HDAC3定位于肉体的一条带,并且能够脱乙酰肌肉重链(MHC)同种型。发现心脏α-和β-MHC同种型的电机结构域是可逆的乙酰化的。生物力学研究表明,α-和β-MHC同种型的肌动蛋白激活的ATP酶活性显着降低了赖氨酸乙酰化显着降低。通过体外动力测定,我们发现与各自的非乙酰化同种型相比,赖氨酸乙酰化将α-霉菌的肌蛋白滑动速度增加了20%和β-肌球蛋白的36%。此外,发现肌蛋白乙酰化对心脏应激敏感。在诱导肥大期间,肌素同种型乙酰化随着胁迫刺激的持续时间而逐渐增加,与同种型移位无关,表明肌苷的乙酰化乙酰化可能是myocilamentes的早期反应,以增加心脏的收缩性能。这些研究提供了HDAC3在myofilaments的第一种证据,并揭示调节心脏MHC同种型的电动机活性的新机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号